The protective function of neutrophil elastase inhibitor in liver ischemia/reperfusion injury

Transplantation

Volumn 89, Issue 9, 2010, Pages 1050-1056

  Uchida, Yoichiro ^a   Freitas, Maria Cecilia S ^a   Zhao, Danyun ^a   Busuttil, Ronald W ^a   Kupiec Weglinski, Jerzy W ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

Ischemia reperfusion injury; Liver; Neutrophil elastase; Toll like receptor 4

Indexed keywords

LEUKOCYTE ELASTASE; SIVELESTAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER GRAFT; LIVER ISCHEMIA; LIVER PROTECTION; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CHEMOKINE CXCL1; DNA PRIMERS; GLYCINE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTE ELASTASE; LIVER; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; PEROXIDASE; POLYMERASE CHAIN REACTION; PROTEINASE INHIBITORY PROTEINS, SECRETORY; REPERFUSION INJURY; RNA; SULFONAMIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951817301     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181d45a98     Document Type: Article

References (52)

1. Farmer DG, Amersi F, Kupiec-Weglinski JW, et al. Current status of ischemia and reperfusion injury in the liver. Transplant Rev 2000; 14: 106.
2. Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003; 18: 891.
3. Tsuchihashi S, Ke B, Kaldas F, et al. Vascular endothelial growth factor antagonist modulates leukocyte trafficking and protects mouse livers against ischemia/reperfusion injury. Am J Pathol 2006; 168: 695.
4. O'Neill LA. Therapeutic targeting of toll-like receptors for inflammatory and infectious diseases. Curr Opin Pharmacol 2003; 3: 396.
5. Obhrai J, Goldstein DR. The role of toll-like receptors in solid organ transplantation. Transplantation 2006; 81: 497.
6. Zhai Y, Shen XD, O'Connell R, et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004; 173: 7115.
7. Zhai Y, Qiao B, Shen XD, et al. Evidence for the pivotal role of endogenous toll-like receptor 4 ligands in liver ischemia and reperfusion injury. Transplantation 2008; 85: 1016.
8. Zhai Y, Shen XD, Gao F, et al. CXCL10 regulates liver innate immune response against ischemia and reperfusion injury. Hepatology 2008; 47: 207.
9. Zhai Y, Qiao B, Gao F, et al. Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion.Hepatology2008; 47: 199.
10. Uchida Y, Freitas MC, Zhao D, et al. The inhibition of neutrophil elastase ameliorates mouse liver damage due to ischemia and reperfu-sion. Liver Transpl 2009; 15: 939.
11. Janoff A, Scherer J. Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activityin granulesof human polymorphonuclear leukocytes. J Exp Med 1968; 128: 1137.
12. Janoff A. Elastase in tissue injury. Annu Rev Med 1985; 36: 207.
13. Mainardi CL, Dixit SN, Kang AH. Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymor-phonuclear leukocyte granules. J Biol Chem 1980; 255: 5435.
14. Mainardi CL, Hasty DL, Seyer JM,etal. Specific cleavage ofhuman type III collagen by human polymorphonuclear leukocyte elastase. J Biol Chem 1980; 255: 12006.
15. Kawabata K, Suzuki M, Sugitani M, et al. ONO-5046, a novel inhibitor of human neutrophil elastase.Biochem Biophys Res Commun1991; 177: 814.
16. Tamakuma S, Ogawa M, Aikawa N, et al. Relationship between neu-trophil elastase and acute lung injury in humans. Pulm Pharmacol Ther 2004; 17: 271.
17. Soejima Y, Yanaga K, Nishizaki T, et al. Effect of specific neutrophil elastase inhibitor on ischemia/reperfusion injury in rat liver transplantation. J Surg Res 1999; 86: 150.
18. Tomizawa N, Ohwada S, Ohya T, et al. The effect of neutrophil elastase inhibitor in hepatectomy with ischemia in dogs. J Surg Res 1999; 81: 230.
19. Kwon AH, Qiu Z. Neutrophil elastase inhibitor prevents endotoxin-induced liver injury following experimental partial hepatectomy. Br J Surg 2007; 94: 609.
20. Ishii K, Ito Y, Katagiri H, et al. Neutrophil elastase inhibitor attenuates lipopolysaccharide-induced hepatic microvascular dysfunction in mice. Shock 2002; 18: 163.
21. NakanoY,KondoT,MatsuoR, etal. Preventionof leukocyte activation by the neutrophil elastase inhibitor, sivelestat, in the hepatic microcir-culation after ischemia-reperfusion. J Surg Res 2009; 155: 311.
22. Shen XD, Ke B, Zhai Y, et al. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection. Hepatology 2003; 37: 296.
23. Tsuchihashi S, Livhits M, Zhai Y, et al. Basal rather than induced heme oxygenase-1 levels are crucial in the antioxidant cytoprotection. J Immunol 2006; 177: 4749.
24. Sakashita A, Nishimura Y, Nishiuma T, et al. Neutrophil elastase inhibitor (sivelestat) attenuates subsequent ventilator-induced lung injury in mice. Eur J Pharmacol 2007; 571: 62.
25. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, et al. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993; 55: 1265.
26. Yoshimura K,NakagawaS, Koyama S,et al. Roles ofneutrophil elastase and superoxide anion in leukotriene B4-induced lung injury in rabbit. J Appl Physiol 1994; 76: 91.
27. Hagio T, Nakao S, Matsuoka H, et al. Inhibition of neutrophil elastase activity attenuates complement-mediated lung injury in the hamster. Eur J Pharmacol 2001; 426: 131.
28. Baggiolini M. Chemokines and leukocyte traffic. Nature1998; 392: 565.
29. Lentsch AB, Yoshidome H, Cheadle WG, et al. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macro-phage inflammatory protein-2 and KC. Hepatology 1998; 27: 1172.
30. Macdonald SJ, Dowle MD, Harrison LA, et al. The discovery of a potent, intracellular, orally bioavailable, long duration inhibitor of human neutrophil elastase\GW311616A a development candidate. Bioorg Med Chem Lett 2001; 11: 895.
31. Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 2007; 35: 757.
32. Scapini P, Lapinet-Vera JA, Gasperini S, et al. The neutrophil as a cellular source of chemokines. Immunol Rev 2000; 177: 195.
33. Mosher B, Dean R, Harkema J, et al. Inhibition of Kupffer cells reduced CXC chemokine production and liver injury. J Surg Res 2001; 99: 201.
34. Oppenheim JJ, Zachariae CO, Mukaida N, et al. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991; 9: 617.
35. Tessier PA, Naccache PH, Clark-Lewis I, et al. Chemokine networks in vivo: Involvement ofC-X-C and C-C chemokines inneutrophil extravasation in vivo in response to TNF-alpha. J Immunol 1997; 159: 3595.
36. Hagiwara S, Iwasaka H, Hidaka S, et al. Neutrophil elastase inhibitor (sivelestat) reduces the levels of inflammatory mediators by inhibiting NF-kB. Inflamm Res 2009; 58: 198.
37. Uchida Y, Kaibori M, Hijikawa T, et al. Protective effect of neutro-phil elastase inhibitor (FR136706) in lethal acute liver failure induced by D-galactosamine and lipopolysaccharide in rats. J Surg Res 2008; 145: 57.
38. Lentsch AB, Kato A, Yoshidome H, et al. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000; 32: 169.
39. Rüdiger HA, Graf R, Clavien PA. Liver ischemia: apoptosis as a central mechanism of injury. J Invest Surg 2003; 16: 149.
40. Tsung A, Hoffman RA, Izuishi K, et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 2005; 175: 7661.
41. Faure E, Equils O, Sieling PA, et al. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR4) in cultured human dermal endothelial cells. J Biol Chem 2000; 275: 11058.
42. Arai M, Mochida S, Ohno A, et al. Selective bowel decontamination of recipients for prevention against liver injury following orthotopic liver transplantation: evaluation with rat models. Hepatology 1998; 27: 123.
43. Fiorini RN, Shafizadeh SF, Polito C, et al. Anti-endotoxin monoclonal antibodies are protective against hepatic ischemia/reperfusion injury in steatotic mice. Am J Transplant 2004; 4: 1567.
44. Tsoulfas G, Takahashi Y, Ganster RW, et al. Activation of the lipopoly-saccharide signaling pathway in hepatic transplantation preservation injury. Transplantation 2002; 74: 7.
45. Wu HS, Zhang JX, Wang L, et al. Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 2004; 3: 250.
46. Shen XD, Ke B, Zhai Y, et al. Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant 2005; 5: 1793.
47. Yeruva S, Ramadori G, Raddatz D. NF-kappaB-dependent synergis-tic regulation of CXCL10 gene expression by IL-1beta and IFN-gamma in human intestinal epithelial cell lines. Int J Colorectal Dis 2008; 23: 305.
48. Qi XF, Kim DH, Yoon YS, et al. Essential involvement of cross-talk betweenIFN-gammaandTNF-alphainCXCL10productioninhuman THP-1 monocytes. J Cell Physiol 2009; 220: 690.
49. Nanji AA, Jokelainen K, Rahemtulla A, et al. Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 1999; 30: 934.
50. Devaney JM, Greene CM, Taggart CC, et al. Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4. FEBS Lett 2003; 544: 129.
51. Tsujimoto H, Ono S, Majima T, et al. Neutrophil elastase, MIP-2, and TLR-4 expression during human and experimental sepsis. Shock 2005; 23: 39.
52. Ribeiro-Gomes FL, Moniz-de-Souza MC, Alexandre-Moreira MS, et al. Neutrophils activate macrophages for intracellular killing of Leish-maniamajor through recruitmentof TLR4 byneutrophil elastase. J Immunol 2007; 179: 3988.